Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation

Apatinib is a new oral tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor-2. It has been proven effective in treating multiple solid tumors. Herein, we report the case of a 67-year-old Chinese patient who was diagnosed with recurrent and malignant transformation of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yongguang, Mai, Weiheng, Chen, Weifeng, Yang, Chao, Li, Mingyi, Liu, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273731/
https://www.ncbi.nlm.nih.gov/pubmed/34262864
http://dx.doi.org/10.3389/fonc.2021.676092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273731/
https://www.ncbi.nlm.nih.gov/pubmed/34262864
http://dx.doi.org/10.3389/fonc.2021.676092

Ejemplares similares